Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2014, Article ID 298767, 7 pages
http://dx.doi.org/10.1155/2014/298767
Research Article

Desmopressin Acetate in Intracranial Haemorrhage

1Neurochirurgische Klinik, Universitätsklinikum Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany
2Klinik für Hämatologie, Onkologie, Immunologie, Palliativmedizin, Infektiologie und Tropenmedizin, Städtisches Klinikum München, Klinikum Schwabing, Kölner Platz 1, 80804 München, Germany
3Klinik für Anästhesiologie, Abteilung Klinische Anästhesiologie, Albert-Einstein-Allee 23, 89081 Ulm, Germany
4Neurochirurgische Klinik, Klinikum Landshut, Robert-Koch-Strasse 1, 84034 Landshut, Germany

Received 29 August 2014; Revised 28 November 2014; Accepted 8 December 2014; Published 23 December 2014

Academic Editor: Jeff Bronstein

Copyright © 2014 Thomas Kapapa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Fintel, “Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options,” Vascular Health and Risk Management, vol. 8, no. 1, pp. 77–89, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-P. Bassand, “Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents,” Europace, vol. 14, no. 3, pp. 312–324, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. Federal Statistical Office of Germany, Prescibtion of Thrombocyte Aggregation Inhibitors in Germany, 2012, https://www.gbe-bund.de.
  4. M. R. Bullock, R. Chesnut, J. Ghajar et al., “Surgical management of acute subdural hematomas,” Neurosurgery, vol. 58, no. 3, pp. S216–S224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Z. Raihan, M. H. Rashid, M. A. Syed, and M. H. Sarkar, “Factors influencing the surgical outcome of spontaneous intracerebral haematoma,” Mymensingh Medical Journal, vol. 18, no. 2, pp. 245–249, 2009. View at Google Scholar · View at Scopus
  6. M. Stanisic, M. Lund-Johansen, and R. Mahesparan, “Treatment of chronic subdural hematoma by burr-hole craniostomy in adults: influence of some factors on postoperative recurrence,” Acta Neurochirurgica, vol. 147, no. 12, pp. 1249–1256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. K.-M. Schebesch, C. Woertgen, R.-D. Rothoerl, O.-W. Ullrich, and A. T. Brawanski, “Cognitive decline as an important sign for an operable cause of dementia: chronic subdural haematoma,” Zentralblatt für Neurochirurgie, vol. 69, no. 2, pp. 61–64, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Baldi, F. Altomonte, M. Altomonte et al., “Intracranial haemorrhage in patients on antithrombotics: Clinical presentation and determinants of outcome in a prospective multicentric study in italian emergency departments,” Cerebrovascular Diseases, vol. 22, no. 4, pp. 286–293, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Saloheimo, M. Ahonen, S. Juvela, J. Pyhtinen, E.-R. Savolainen, and M. Hillbom, “Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death,” Stroke, vol. 37, no. 1, pp. 129–133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. K.-H. Beck, P. Mohr, U. Bleckmann, H. Schweer, and V. Kretschmer, “Desmopressin effect on acetylsalicylic acid impaired platelet function,” Seminars in Thrombosis and Hemostasis, vol. 21, supplement 2, pp. 32–39, 1995. View at Google Scholar · View at Scopus
  11. K. H. Beck, U. Bleckmann, P. Mohr, V. Kretschmer, and B. Huss, “Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin,” Beiträge zur Infusionstherapie und Transfusionsmedizin, vol. 32, pp. 437–439, 1994. View at Google Scholar · View at Scopus
  12. D. P. Sheridan, R. T. Card, J. C. Pinilla et al., “Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction,” Canadian Journal of Surgery, vol. 37, no. 1, pp. 33–36, 1994. View at Google Scholar · View at Scopus
  13. P. A. Flordal and S. Sahlin, “Use of desmopressin to prevent bleeding complications in patients treated with aspirin,” British Journal of Surgery, vol. 80, no. 6, pp. 723–724, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Schulman, “Pharmacologic tools to reduce bleeding in surgery,” Hematology: The Education Program of the American Society of Hematology, vol. 2012, pp. 517–521, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Lethagen, “Desmopressin (DDAVP) and hemostasis,” Annals of Hematology, vol. 69, no. 4, pp. 173–180, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Arzneimittel, Fachinformation MINIRIN Parenteral, 2011.
  17. I. F. K. C. Universitätsklinikum-Köln, Aufbau und Funktionsweise des PFA-100, 2012, http://www.unsere-uniklinik.de/institute/kchemie/Parameter.html.
  18. R. Karger, K. Reuter, J. Rohlfs, C. Nimsky, U. Sure, and V. Kretschmer, “The platelet function analyzer (PFA-100) as a screening tool in neurosurgery,” ISRN Hematology, vol. 2012, Article ID 839242, 7 pages, 2012. View at Publisher · View at Google Scholar
  19. H. Alahmadi, S. Vachhrajani, and M. D. Cusimano, “The natural history of brain contusion: an analysis of radiological and clinical progression: clinical article,” Journal of Neurosurgery, vol. 112, no. 5, pp. 1139–1145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Kurland, C. Hong, B. Aarabi, V. Gerzanich, and J. M. Simard, “Hemorrhagic progression of a contusion after traumatic brain injury: a review,” Journal of Neurotrauma, vol. 29, no. 1, pp. 19–31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. G. M. Van Beek, N. A. Mushkudiani, E. W. Steyerberg et al., “Prognostic value of admission laboratory parameters in traumatic brain injury: results from the IMPACT study,” Journal of Neurotrauma, vol. 24, no. 2, pp. 315–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Schulz-Stübner, D. Zielske, and R. Rossaint, “Comparison between nasal and intravenous desmopressin for the treatment of aminosalicylic acid-induced platelet dysfunction,” European Journal of Anaesthesiology, vol. 19, no. 9, pp. 647–651, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. P. A. Kouides, V. R. Byams, C. S. Philipp et al., “Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid,” British Journal of Haematology, vol. 145, no. 2, pp. 212–220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. C. Guth, L. Kaufner, C. Kleber, and C. von Heymann, “Therapy of trauma-induced coagulopathy—what is the evidence?” Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie, vol. 49, no. 9, pp. 528–540, 2012. View at Google Scholar
  25. R. A. Reiter, F. Mayr, H. Blazicek et al., “Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin,” Blood, vol. 102, no. 13, pp. 4594–4599, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. J. S. Batchelor and A. Grayson, “A meta-analysis to determine the effect on survival of platelet transfusions in patients with either spontaneous or traumatic antiplatelet medication-associated intracranial haemorrhage,” BMJ Open, vol. 2, no. 2, Article ID e000588, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Taylor, D. Osinski, A. Thevenin, and J.-M. Devys, “Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and/or clopidogrel before emergency surgery?” Journal of Trauma and Acute Care Surgery, vol. 74, no. 5, pp. 1367–1369, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. C. W. Washington, D. J. E. Schuerer, and R. L. Grubb, “Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy,” Journal of Trauma—Injury, Infection and Critical Care, vol. 71, no. 2, pp. 358–363, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. P. M. Mannucci and M. Levi, “Drug therapy: prevention and treatment of major blood loss,” The New England Journal of Medicine, vol. 356, no. 22, pp. 2301–2311, 2007. View at Publisher · View at Google Scholar · View at Scopus